Tags

Type your tag names separated by a space and hit enter

Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia.
Leukemia. 2020 11; 34(11):3047-3049.L

Authors+Show Affiliations

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. roekerl@mskcc.org.Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ, USA.Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

32855439

Citation

Roeker, Lindsey E., et al. "Anti-SARS-CoV-2 Antibody Response in Patients With Chronic Lymphocytic Leukemia." Leukemia, vol. 34, no. 11, 2020, pp. 3047-3049.
Roeker LE, Knorr DA, Pessin MS, et al. Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia. Leukemia. 2020;34(11):3047-3049.
Roeker, L. E., Knorr, D. A., Pessin, M. S., Ramanathan, L. V., Thompson, M. C., Leslie, L. A., Zelenetz, A. D., & Mato, A. R. (2020). Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia. Leukemia, 34(11), 3047-3049. https://doi.org/10.1038/s41375-020-01030-2
Roeker LE, et al. Anti-SARS-CoV-2 Antibody Response in Patients With Chronic Lymphocytic Leukemia. Leukemia. 2020;34(11):3047-3049. PubMed PMID: 32855439.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia. AU - Roeker,Lindsey E, AU - Knorr,David A, AU - Pessin,Melissa S, AU - Ramanathan,Lakshmi V, AU - Thompson,Meghan C, AU - Leslie,Lori A, AU - Zelenetz,Andrew D, AU - Mato,Anthony R, Y1 - 2020/08/27/ PY - 2020/07/27/received PY - 2020/08/12/accepted PY - 2020/08/01/revised PY - 2020/8/29/pubmed PY - 2020/11/6/medline PY - 2020/8/29/entrez SP - 3047 EP - 3049 JF - Leukemia JO - Leukemia VL - 34 IS - 11 SN - 1476-5551 UR - https://www.unboundmedicine.com/medline/citation/32855439/Anti_SARS_CoV_2_antibody_response_in_patients_with_chronic_lymphocytic_leukemia_ DB - PRIME DP - Unbound Medicine ER -